Skip to Main Content

Paper Details

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial.
Nat Med
140
2022
HER2, HER2-positive breast cancer, Patients, Trastuzumab, brain metastases, human, human epidermal growth factor receptor 2, human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, neuro-, patients, pertuzumab, trastuzumab, trastuzumab deruxtecan
Author NameAffiliation
Anna S BerghoffMedical University of Vienna
Julia FurtnerMedical University of Vienna
Karin DieckmannMedical University of Vienna
Georg WidhalmMedical University of Vienna
Matthias PreusserMedical University of Vienna
Matthias PreusserMedical University of Vienna
  • 1 - 6

Datasets

Release 1.2